South Korea Antimicrobial Susceptibility Testing Market Insight
Published: 05 June 2026 | Report Format: Electronic (PDF)
The South Korean antimicrobial susceptibility testing market is expected to experience an increase at a rate of 6.97% owing to rising antimicrobial resistance cases, growing demand for rapid diagnostics, increased healthcare investments, and adoption of automated laboratory testing technologies.
South Korea Antimicrobial Susceptibility Testing Market Insights Forecasts to 2035
- The South Korea Antimicrobial Susceptibility Testing Market Size Was Estimated USD 214.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.97% from 2025 to 2035
- The South Korea Antimicrobial Susceptibility Testing Market Size is Expected to rise around USD 421.2 Million by 2035
Notable Insights for the South Korea Antimicrobial Susceptibility Testing Market
- The product-based segmentation indicates that the Automated Antimicrobial Susceptibility Testing Systems segment holds commanding position with almost 57% market share South Korea Antimicrobial Susceptibility Testing Market 2025 due to increasing adoption in hospitals, diagnostic laboratories.
- The application-based segmentation shows that the Hospitals, segment dominates with a market share of almost 63% South Korea Antimicrobial Susceptibility Testing Market in 2025 result increasing prevalence of infectious diseases and antimicrobial resistance monitoring programs.
- The global revenue for bioMérieux S.A. in fiscal year 2025 was estimated at about $4.8 billion, driven by rising demand for microbiology diagnostics, infectious disease testing, and antimicrobial susceptibility solutions.
- As per expectations, rising laboratory automation trends programs along with advanced diagnostic requirements will drive market expansion which antimicrobial susceptibility testing improves pathogen detection accuracy up to 46% reduces diagnostic turnaround time up to 34%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea Antimicrobial Susceptibility Testing Market
The South Korea antimicrobial susceptibility testing market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with diagnostic equipment manufacturers, healthcare organizations, microbiology laboratories, hospitals, distributors, and industry experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, healthcare journals, scientific publications, infectious disease databases, and laboratory medicine organizations in connection with microbiology diagnostics and antimicrobial resistance testing. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Antimicrobial Susceptibility Testing Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Antimicrobial Susceptibility Testing Market
- bioMérieux S.A.
- Becton, Dickinson and Company (BD)
- Thermo Fisher Scientific Inc.
- Danaher Corporation (Beckman Coulter)
- Bruker Corporation
- Bio-Rad Laboratories, Inc.
- Accelerate Diagnostics, Inc.
- Merck KGaA
- Sysmex Corporation
- Seegene Inc.
Recent Developments:
- In January 2026, BioMérieux S.A. expanded its antimicrobial susceptibility testing portfolio with advanced automated microbiology systems designed for rapid pathogen identification and antimicrobial resistance monitoring application.
- In August 2025, Becton, Dickinson and Company (BD) introduced next-generation antimicrobial susceptibility testing solutions integrated with automated laboratory workflow technologies for clinical diagnostics and infectious disease management.
Market Segmentation:
South Korea Antimicrobial Susceptibility Testing Market, By Product Type
- Automated Antimicrobial Susceptibility Testing Systems
- Manual Antimicrobial Susceptibility Testing Products
- Consumables & Reagents
- Culture Media
- Diagnostic Panels
South Korea Antimicrobial Susceptibility Testing Market, By Technology
- Automated Microbiology Testing Systems
- Molecular Diagnostic Technologies
- Phenotypic Susceptibility Testing
- Genotypic Resistance Detection Technologies
- AI-Enabled Laboratory Analysis Platforms
South Korea Antimicrobial Susceptibility Testing Market, By Application
- Hospitals
- Clinical Diagnostics Laboratories
- Microbiology Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Expert Views:
The growth of antimicrobial susceptibility testing markets in South Korea will be facilitated by increasing antimicrobial resistance cases, growing infectious disease burden, and higher demand for rapid diagnostic solutions. The use of automated microbiology systems, molecular diagnostic technologies, and AI-driven laboratory analysis platforms will contribute to improved testing efficiency and enhanced demand in hospitals, clinical diagnostics, microbiology laboratories, pharmaceutical research, and infectious disease management markets in South Korea.
Author: Govind and Krishna By Spherical Insights and Consulting